Company intelligence / Profile preview

Tri Puspa Pharma

Bekasi, West Java, Indonesia

Ownership: Private
Development stage: Other

Overview

Tri Puspa Pharma is an Indonesian pharmaceutical manufacturing company focused on the production and distribution of generic and over-the-counter (OTC) medicines. The company operates a manufacturing facility that complies with Good Manufacturing Practices (CPOB) to ensure the quality of its diverse product portfolio, which includes antibiotics, analgesics, and vitamins. Tri Puspa Pharma serves the domestic Indonesian healthcare market by providing affordable therapeutic options across various medical categories. Their business model emphasizes manufacturing excellence and broad distribution to healthcare providers and pharmacies throughout the region.

Therapeutic areas: NeurologyInfectious DiseasesPulmonologyGastroenterologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Tri Puspa Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tri Puspa Pharma.

Explore the full profile